Nuveen Asset Management, LLC Regenxbio Inc. Transaction History

Nuveen Asset Management, LLC

$334 Billion
Q2 2024

A detailed history of Nuveen Asset Management, LLC transactions in Regenxbio Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 112,316 shares of RGNX stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,316

Previous 105,768 6.19%

Holding current value

$1.05 Million

Previous $2.23 Million 41.02%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$11.51 - $21.53 $75,367 - $140,978	6,548 Added 6.19%	112,316 $1.31 Million
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $46,287 - $74,764	3,591 Added 3.51%	105,768 $1.9 Million
Q3 2023 Nov 14, 2023	SELL	$16.46 - $19.99 $22,451 - $27,266	-1,364 Reduced 1.32%	102,177 $1.68 Million
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $256,482 - $348,266	-14,186 Reduced 12.05%	103,541 $1.96 Million
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $359,856 - $436,237	-17,640 Reduced 13.03%	117,727 $2.67 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $88,892 - $139,739	-3,988 Reduced 2.86%	135,367 $3.58 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $249,402 - $451,630	12,889 Added 10.19%	139,355 $3.44 Million
Q1 2022 May 16, 2022	SELL	$24.62 - $34.31 $10,266 - $14,307	-417 Reduced 0.33%	126,466 $3.68 Million
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $320,497 - $427,612	-10,616 Reduced 7.72%	126,883 $3.97 Million
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $344,425 - $540,851	-11,840 Reduced 7.93%	137,499 $6.19 Million
Q2 2021 Aug 16, 2021	SELL	$32.46 - $40.48 $523,514 - $652,861	-16,128 Reduced 9.75%	149,339 $5.8 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $1.22 Million - $1.82 Million	36,370 Added 28.17%	165,467 $5.64 Million
Q4 2020 Feb 16, 2021	SELL	$26.52 - $49.35 $66,353 - $123,473	-2,502 Reduced 1.9%	129,097 $5.86 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $335,626 - $500,270	-12,426 Reduced 8.63%	131,599 $3.62 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $121,822 - $190,701	4,390 Added 3.14%	144,025 $5.3 Million
Q1 2020 May 14, 2020	BUY	$21.5 - $54.2 $31,067 - $78,319	1,445 Added 1.05%	139,635 $4.52 Million
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $1.48 Million - $1.93 Million	-42,929 Reduced 23.7%	138,190 $5.66 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $559,014 - $893,300	-17,557 Reduced 8.84%	181,119 $6.45 Million
Q2 2019 Aug 15, 2019	BUY	$42.0 - $59.29 $8.34 Million - $11.8 Million	198,676 New	198,676 $10.2 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Regenxbio Inc. Transaction History